Bladder Cancer - Results from #360

REVIEW UroToday

Income Disparities in Survival and Receipt of Neoadjuvant Chemotherapy and Pelvic Lymph Node Dissection for Muscle-Invasive Bladder Cancer. May 27, 2024

Immune features are associated with response to neoadjuvant chemo-immunotherapy for muscle-invasive bladder cancer. May 27, 2024

Treatment Modalities for Non-Muscle Invasive Bladder Cancer: An Updated Review. May 27, 2024

Systematic review of recent advancements in antibody-drug and bicycle toxin conjugates for the treatment of urothelial cancer. May 24, 2024

Efficiency of bladder-sparing strategies for bladder cancer: an umbrella review. May 24, 2024

Advancements in Urothelial Cancer Care: Optimizing Treatment for Your Patient. May 23, 2024

How Immunotherapy Has Redefined the Treatment Paradigm of Metastatic or Locally Advanced Muscle-Invasive Urothelial Bladder Carcinoma. May 23, 2024

Phase 2 Study of Preoperative Tislelizumab in Combination with Low-dose Nab-Paclitaxel in Patients with Muscle-invasive Bladder Cancer. May 22, 2024

C-Reactive Protein Is a Potential Prognostic Marker in Patient with Advanced or Metastatic Urothelial Carcinoma Treated with Enfortumab Vedotin: A Multi-Center Retrospective Study. May 22, 2024

Social Vulnerability and Receipt of Neoadjuvant Chemotherapy in Patients Undergoing Radical Cystectomy for Bladder Cancer. May 21, 2024

Adjuvant Chemotherapy and Survival After Radical Cystectomy in Histologic Subtype Bladder Cancer. May 21, 2024

Chemotherapy, immunotherapy, or combination first-line treatment for metastatic urothelial carcinoma of the bladder: A large real-world experience. May 21, 2024

Clofarabine Has a Superior Therapeutic Window as compared to Gemcitabine in Preclinical Bladder Cancer Models. May 20, 2024

Bladder Cancer, Version 3.2024. May 20, 2024

The impact of purified protein derivative prior to intravesical bacillus Calmette-Guérin for the treatment of patients with non-muscle invasive bladder cancer. May 20, 2024

Role of Gut Microbiome in Neoadjuvant Chemotherapy Response in Urothelial Carcinoma: A Multi-Institutional Prospective Cohort Evaluation. May 17, 2024

Variation in Follow-Up after Radical Cystectomy for Bladder Cancer-An Inventory Roundtable and Literature Review. May 17, 2024

Acu-URO17 is a highly sensitive and specific bladder cancer biomarker. May 17, 2024

Natural Killer Cell Dysfunction In Human Bladder Cancer Is Caused By Tissue-Specific Suppression of SLAMF6 Signaling. May 16, 2024

Patient-Reported Outcomes after Laser Ablation for Bladder Tumours Compared to Transurethral Resection-A Prospective Study. May 16, 2024

Page 19 of 517